Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 211741

Страница 1 из 21175

FINE-MAPPING OF 150 BREAST CANCER RISK REGIONS IDENTIFIES 191 LIKELY TARGET GENES

Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)) with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated

Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the breast cancer association consortium studies
Yang X.R., Chang-Claude J., Fischer H.P., Eccles D.M., Holland H., Dite G.S., Hopper J.L., Hammet F., Goode E.L., Lubiński J., Huzarski T., Hooning M.J., Kosma V.M., Couch F.J., Chenevix-Trench G., Apicella C., Nevanlinna H., Hamann U., Tapper W.J., Jakubowska A., Kriege M., Manoukian S., Barile M., Milne R.L., Pesch B., Brüning T., Byrski T., Tilanus-Linthorst M.M.A., Pylkäs K., Mononen K., Grip M., Dynnes Ørsted D., Nordestgaard B.G., Hankinson S.E., Sangrajrang S., McKay J., Tollenaar R., Seynaeve C., Gaudet M., Justenhoven C., Górski B., Jukkola-Vuorinen A., Kauppinen J., Soini Y., Brennan P., Schmidt M.K., Rodríguez P.M., Gronwald J., Hirvikoski P., Winqvist R., Mannermaa A., Kataja V., Sironen R., Kaur-Knudsen D., Broeks A., Auvinen P., Cox A., Garcia-Closas M., Fasching P.A., Hein R., Sherman M.E., Spurdle A.B., Blows F., Driver K., Flesch-Janys D., Heinz J., Sinn P., Vrieling A., Heikkinen T., Aittomäki K., Heikkilä P., Blomqvist C., Pharoah P., Lissowska J., Yu J.C., Chen S.T., Peplonska B., Chanock S., Figueroa J., Brinton L., Hall P., Czene K., Humphreys K., Darabi H., Liu J., Van 'T Veer L.J., Gerty S.M., Yang S.L., Flyger H., Tsimiklis H., Van Leeuwen F.E., Andrulis I.L., Glendon G., Knight J.A., Mulligan A.M., O'Malley F.P., Weerasooriya N., John E.M., Shen C.Y., Beckmann M.W., Hartmann A., Weihbrecht S.B., Tomlinson I.P., Hsu G.C., Haiman C.A., Henderson B.E., Le Marchand L., Van Den Ouweland A.M.W., Southey M.C., Wachter D.L., Sawyer E.J., Miller N., Gaborieau V., Jud S.M., Loehberg C.R., Baglietto L., English D.R., Giles G.G., McLean C.A., Severi G., Kerin M., Lambrechts D., Brauch H., Margolin S., Vandorpe T., Wang-Gohrke S., Smith L.D., Weltens C., Hsiung C.N., Wu P.E., Jager A., Odefrey F., Devilee P., Paridaens R., Smeets A., Neven P., Wildiers H., Wang X., Olson J.E., Cafourek V., Jones A., Fredericksen Z., Kosel M., Humphreys M.K., Vachon C., Huijts P.E.A., Easton D., Cramp H.E., McInerney N., Lindblom A., Hollestelle A., Hunter D.J., Connley D., Cross S.S., Balasubramanian S.P., Reed M.W.R., Dörk T., Bremer M., Radice P., Meyer A., Karstens J.H., Ay A., Tamimi R., Park-Simon T.W., Hillemanns P., Anton-Culver H., Kolonel L.N., Bojesen S.E., Arias Pérez J.I., Ziogas A., Zamora P., Benítez J., Ko Y.D., Collée M.
at menarche (≤12 years) was less frequent in case patients with PR- than PR+ tumors (P

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Wei-Yu Lin, Reed M.W.R., Cox A., Camp N.J., Ghoussaini M., Michailidou K., Bolla M.K., Wang Q., Dennis J., Pharoah P.D.P., Easton D.F., Perkins B., Shah M., Blows F.M., Luccarini C., Baynes C., Ahmed S., Maranian M., Healey C.S., Dunning A., Beesley J., Chenevix-Trench G., Hopper J.L., Apicella C., Giles G.G., Milne R.L., Southey M.C., Stone J., Tsimiklis H., Makalic E., Schmidt D.F., Bui Q.M., Schmidt M.K., Broeks A., Van't Veer L.J., Th Rutgers E.J., Muir K., Lophatananon A., Stewart-Brown S., Siriwanarangsan P., Fasching P.A., Haeberle L., Beckmann M.W., Ekici A.B., Peto J., Dos-Santos-Silva I., Fletcher O., Johnson N., García-Closas M., Ashworth A., Orr N., Sawyer E.J., Cheng T., Tomlinson I., Kerin M.J., Miller N., Frederik Marmé, Surowy H.M., Burwinkel B., Brenner H., Dieffenbach A.K., Arndt V., Brauch H., Chang-Claude J., Rudolph A., Seibold P., Hamann U., Hein R., Guénel P., Truong T., Menegaux F., Mulot C., Bojesen S.E., Nordestgaard B.G., Nielsen S.F., Flyger H., Benitez J., González-Neira A., Pita G., Rosario Alonso M., Álvarez N., Herrero D., Pilar Zamora M., Perez J.I.A., Menéndez P., Anton-Culver H., Stegmaier C., Meindl A., Lichtner P., Schmutzler R.K., Müller-Myhsok B., Brüning T., Ko Y.D., Tessier D.C., Vincent D., Bacot F., Nevanlinna H., Khan S., Aaltonen K., Muranen T.A., Heikkinen T., Aittomäki K., Blomqvist C., Matsuo K., Ito H., Iwata H., Horio A., Bogdanova N.V., Dörk T., Antonenkova N.N., Lindblom A., Margolin S., Czene K., Darabi H., Eriksson M., Brand J.S., Humphreys K., Hall P., Mannermaa A., Kosma V.M., Hartikainen J.M., Kataja V., Wu A.H., Tseng C.C., Van Den Berg D., Stram D.O., Haiman C.A., Henderson B.E., Schumacher F., Neven P., Wauters E., Lambrechts D., Wildiers H., Flesch-Janys D., Radice P., Manoukian S., Peterlongo P., Bonanni B., Couch F.J., Wang X., Vachon C., Slager S., Purrington K., Mclean C., Marchand L.L., Simard J., Dumont M., Goldberg M.S., Labrèche F., Teo S.H., Hassan N., Yip C.H., Vithana E.N., Kristensen V., Zheng W., Deming-Halverson S., Shrubsole M.J., Long J., Shu X.O., Cai H., Blot W., Signorello L.B., Cai Q., Winqvist R., Pylkäs K., Jukkola-Vuorinen A., Kauppila S., Andrulis I.L., Glendon G., Knight J.A., Tchatchou S., Devilee P., Tollenaar R.A.E.M., Van Asperen C.J., Seynaeve C., Hooning M.J., Hollestelle A., Jager A., Jones M., Swerdlow A.J., Rahman N., Turnbull C.A., Van Der Luijt R.B., Figueroa J., Brinton L., Chanock S.J., Lissowska J., Van DenOuweland A.M.W., Liu J., Irwanto A., Li J., Lu W., Gao Y.T., Cross S.S., Kang D., Noh D.Y., Yoo K.Y., Hartman M., Miao H., Chia K.S., Putti T.C., Jakubowska A., Lubinski J., Jaworska-Bieniek K., Durda K., Sangrajrang S., Gaborieau V., Brennan P., Mckay J., Toland A.E., Yannoukakos D., Shen C.Y., Hsiung C.N., Wu P.E., Ding S.L., Hunter D.J., Dahmen N., Beckmann L., Waisfisz Q., Meijers-Heijboer H.E.J., Adank M.A.

GENOME-WIDE ASSOCIATION STUDY IDENTIFIES 32 NOVEL BREAST CANCER SUSCEPTIBILITY LOCI FROM OVERALL AND SUBTYPE-SPECIFIC ANALYSES and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 × 10−8), 15 of which showed evidence

Времена жизни 5p³ ¹P⁰₁, 6p¹ P¹, np ¹D₂(n=7,8), 6p³S₁, 7p³P₁, 6p³D₂, 5d³P⁰, 6d³D⁰ уровней иона сурьмыВремена жизни 5p³ ¹P⁰₁, 6p¹ P¹, np ¹D₂(n=7,8), 6p³S₁, 7p³P₁, 6p³D₂, 5d³P⁰, 6d³D⁰ уровней иона

ATpase-deficient mitochondrial inner membrane protein ATAD3a disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia variant c.1064G>A (p. G355D) in ATAD3A in a mother presenting with hereditary spastic paraplegia (HSP

Асимптотические формулы для числа решений некоторых диофантовых уравнений

THE FANCM:P.ARG658* TRUNCATING VARIANT IS ASSOCIATED WITH RISK OF TRIPLE-NEGATIVE BREAST CANCER recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association

THE FANCM:P.ARG658* TRUNCATING VARIANT IS ASSOCIATED WITH RISK OF TRIPLE-NEGATIVE BREAST CANCER recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association

Страница 1 из 21175